1854 studies found for:    Alzheimer's
Show Display Options
Rank Status Study
21 Unknown  Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study
Condition: Alzheimer's Disease
Intervention: Drug: F18-AV45
22 Completed
Has Results
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Varenicline;   Drug: Placebo
23 Completed
Has Results
Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
24 Recruiting A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: CAD106 Immunotherapy;   Other: Placebo to CAD106;   Drug: CNP520;   Other: Placebo to CNP520
25 Completed
Has Results
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Interferon beta-1a;   Drug: Placebo
26 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD);   Significant Memory Concern (SMC);   Early Mild Cognitive Impairment (EMCI);   Late Mild Cognitive Impairment (LMCI)
Intervention:
27 Completed Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
Condition: Alzheimer's Disease
Intervention: Other: Actigraphy and video recording signal
28 Recruiting Benfotiamine in Alzheimer's Disease: A Pilot Study
Condition: Alzheimer's Disease
Intervention: Drug: Benfotiamine
29 Completed
Has Results
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Condition: Alzheimer Disease
Interventions: Drug: Rivastigmine 5 cm^2;   Drug: Rivastigmine 10 cm^2;   Drug: Rivastigmine 15 cm^2;   Drug: Placebo to 15 cm^2 patch;   Drug: Placebo to 10 cm^2 patch
30 Recruiting Hearing Instruments in Alzheimer's Disease
Conditions: Alzheimer Disease;   Hearing Loss
Interventions: Device: Standard audiologic rehabilitation (incl. HI);   Device: Activity tracker
31 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
32 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
33 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
34 Recruiting Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Conditions: Alzheimers Disease;   Postoperative Delirium;   Post Operative Cognitive Dysfunction
Interventions: Drug: Total intravenous anesthesia with propofol;   Drug: General anesthesia with isoflurane
35 Completed
Has Results
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine Patch;   Drug: Rivastigmine Capsules;   Drug: Placebo to Rivastigmine patch;   Drug: Placebo to Rivastigmine capsules
36 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
37 Completed
Has Results
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Placebo Control;   Drug: ELND005
38 Completed
Has Results
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention: Drug: Flutemetamol (18F) Injection
39 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
40 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years